A case of chronic eosinophilic pneumonia in a patient treated with dupilumab

The increasing knowledge on inflammatory pathways has driven the development of targeted biological therapies for severe refractory asthma. Among the recently developed biologics, the fully human monoclonal antibody dupilumab is an interesting therapeutic option, given its ability to inhibit the bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzella, Francesco, Montanari, Gloria, Patricelli, Giulia, Cavazza, Alberto, Galeone, Carla, Ruggiero, Patrizia, Bagnasco, Diego, Facciolongo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636310/
https://www.ncbi.nlm.nih.gov/pubmed/31371974
http://dx.doi.org/10.2147/TCRM.S207402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636310/
https://www.ncbi.nlm.nih.gov/pubmed/31371974
http://dx.doi.org/10.2147/TCRM.S207402

Ejemplares similares